Animal Health and Veterinary Pharmaceutical Stocks in India with Strong Future Roadmaps as Livestock Productivity Focus, Export Growth, and Companion Animal Care Expansion Drive Structural Demand
- August 27, 2026
- Posted by: Kunal Singla
- Category: Market
India animal health market FY26: Rs 10,000 Cr+. Sequent Scientific MCap Rs 12,238 Cr, PE 45.83 above sector 37.20, ROE 7.07%. Thin listed pure-play universe. CAUTION: single dominant listed player. 5 picks: SEQUENT, VIRBAC(unlisted ref), VENKYS(adjacent ref), ZYDUSANIMAL(unlisted ref), INDIANIMMUNO(unlisted ref).
Quick Answer
Sequent Scientific is India’s primary listed animal health and veterinary pharmaceutical stock, manufacturing veterinary APIs and formulations for global markets, trading at PE 45.83, above the animal health and veterinary pharmaceutical stocks sector PE of 37.20, with a modest ROE of 7.07%. India’s animal health sector, historically served largely through unlisted or subsidiary structures of larger pharmaceutical companies, benefits from growing livestock productivity focus, export demand for veterinary pharmaceuticals, and expanding companion animal care in urban India.
India’s animal health sector serves both the large livestock population (requiring productivity-focused veterinary medicine for dairy cattle, poultry, and other farm animals) and a growing companion animal care segment in urban India, as pet ownership rises alongside increasing willingness to spend on pet healthcare. Export opportunities exist for Indian veterinary pharmaceutical manufacturers given India’s broader generic pharmaceutical manufacturing expertise extending naturally to veterinary applications.
For investors, this thin sector centers on Sequent Scientific as the primary viable listed option. All data is as of 26 August 2026.
Click Here – Get Free Investment Predictions
What Are Animal Health and Veterinary Pharmaceutical Stocks in India?
Animal health and veterinary pharmaceutical stocks are shares in companies manufacturing veterinary medicines, vaccines, and health products for livestock and companion animals. India’s listed universe is thin, anchored primarily by Sequent Scientific, which manufactures veterinary active pharmaceutical ingredients and formulations for global markets, while several other significant veterinary pharmaceutical companies including Virbac Animal Health India and Zydus Animal Health operate as subsidiaries of larger groups without separate meaningful listed access.
Budget 2026-27 Impact on Animal Health and Veterinary Pharmaceutical Stocks
Click Here – Get Free Investment Predictions
- Growing livestock productivity focus creating structural veterinary medicine demand for animal health and veterinary pharmaceutical stocks.
- Export opportunity leveraging India’s generic pharmaceutical manufacturing expertise for animal health and veterinary pharmaceutical stocks.
- Expanding companion animal care in urban India creating new demand category for animal health and veterinary pharmaceutical stocks.
- Dairy sector modernisation requiring veterinary health management for animal health and veterinary pharmaceutical stocks.
- Poultry and aquaculture health product demand supporting animal health and veterinary pharmaceutical stocks growth.
5 Animal Health and Veterinary Pharmaceutical Stocks in India to Watch in 2026
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E Ratio | ROE (%) |
|---|---|---|---|---|
| Sequent Scientific | 280 | 12,238 | 45.83 | 7.07% |
| Virbac Animal Health India (subsidiary reference) | N/A | N/A | N/A | N/A% |
| Venky’s India (poultry health adjacent reference) | 1,578 | 2,222 | 12.82 | 8.72% |
| Zydus Animal Health (subsidiary reference) | N/A | N/A | N/A | N/A% |
| Indian Immunologicals (unlisted PSU-linked reference) | N/A | N/A | N/A | N/A% |
Data as of 25 August 2026. For 52-week high/low, verify at nseindia.com before making any investment decision.
1. Sequent Scientific (NSE: SEQUENT)
Sequent Scientific is India’s primary listed animal health and veterinary pharmaceutical stock, manufacturing veterinary APIs and formulations for global markets. Market cap is Rs 12,238 crore. PE is 45.83 (above sector 37.20), ROE is 7.07%, D/E is 0.17. Sequent Scientific’s global veterinary pharmaceutical manufacturing scale makes it the primary viable choice among animal health and veterinary pharmaceutical stocks.
2. Virbac Animal Health India (subsidiary reference) (NSE: N/A)
Virbac Animal Health India, the Indian subsidiary of French veterinary pharmaceutical company Virbac, operates without meaningful standalone public listing access for animal health and veterinary pharmaceutical stocks investors.
3. Venky’s India (poultry health adjacent reference) (NSE: VENKYS)
Venky’s India, primarily a poultry and animal feed company, has adjacent animal health product interests, though its core business remains poultry farming and feed rather than pure veterinary pharmaceuticals.
4. Zydus Animal Health (subsidiary reference) (NSE: N/A)
Zydus Animal Health operates as part of the broader Zydus Lifesciences pharmaceutical group rather than as a separately listed animal health and veterinary pharmaceutical stock.
Download the Univest iOS App or Univest Android App to track live prices and expert research.
5. Indian Immunologicals (unlisted PSU-linked reference) (NSE: N/A)
Indian Immunologicals, a significant animal vaccine manufacturer linked to the National Dairy Development Board, remains outside direct public equity access for animal health and veterinary pharmaceutical stocks investors.
What Factors Affect Animal Health and Veterinary Pharmaceutical Stocks?
- Sequent Scientific’s global veterinary formulation export order growth as demand indicator.
- Livestock productivity policy focus as structural demand indicator for animal health and veterinary pharmaceutical stocks.
- Companion animal care spending growth in urban India as new demand category indicator.
- Regulatory approval trends for veterinary pharmaceuticals affecting market access.
- Raw material and API cost trends affecting margins for animal health and veterinary pharmaceutical stocks.
Benefits of Investing in Animal Health and Veterinary Pharmaceutical Stocks
- Sequent Scientific’s global manufacturing scale providing export revenue diversification.
- India’s generic pharmaceutical manufacturing expertise extending naturally to veterinary applications.
- Growing companion animal care spending creating new demand category.
- Livestock productivity focus providing structural baseline demand.
- Export opportunities to developed and developing markets for animal health and veterinary pharmaceutical stocks.
Risks to Consider Before Investing
- Extremely thin listed universe creating concentration risk for animal health and veterinary pharmaceutical stocks investors.
- Sequent Scientific’s premium PE requiring sustained growth execution.
- Regulatory approval delays affecting market access for veterinary pharmaceuticals.
- Competition from established global veterinary pharmaceutical companies.
- Currency fluctuation risk for export-oriented animal health and veterinary pharmaceutical stocks.
How to Choose Animal Health and Veterinary Pharmaceutical Stocks
- Sequent Scientific is currently the only viable listed option in this thin sector.
- Monitor export order growth and companion animal care spending trends.
- Accept concentration risk given the extremely limited listed universe.
- Consider the animal health and veterinary pharmaceutical stocks sector a smaller satellite holding given limited diversification.
- Track regulatory approval trends for veterinary pharmaceutical products.
How to Invest in Animal Health and Veterinary Pharmaceutical Stocks in India
Step 1: Open a SEBI-registered demat account. Univest offers zero-brokerage broking with integrated research, so you can screen, research, and invest in animal health and veterinary pharmaceutical stocks from one platform.
Step 2: Use the Univest Screener to filter the animal health and veterinary pharmaceutical stocks sector by PE, ROE, D/E, and revenue growth. This gives you a ranked snapshot of all listed animal health and veterinary pharmaceutical companies.
Step 3: Review financial statements of your shortlist. Look at three-year revenue trends, net profit margins, and operating cash flows. Single-quarter numbers are not a sufficient basis for long-term allocation in the animal health and veterinary pharmaceutical stocks sector.
Step 4: Decide on position size based on your risk tolerance. High-growth animal health and veterinary pharmaceutical stocks carry more volatility than diversified blue-chips. Diversify across two or three names rather than concentrating in one.
Step 5: Set price alerts and monitor quarterly results. The Univest app lets you track analyst views and set real-time alerts so you stay informed on order inflows, margin trends, and management guidance.
Conclusion
India’s animal health and veterinary pharmaceutical stocks sector is concentrated around Sequent Scientific, trading at PE 45.83 with ROE 7.07%, as the primary listed option in a thin universe. Growing livestock productivity focus, export opportunities, and expanding companion animal care create structural growth potential, though the concentrated listed universe limits diversification. Consult a SEBI-registered investment advisor before making any investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Animal Health and Veterinary Pharmaceutical Stocks in India 2026
Which are the animal health and veterinary pharmaceutical stocks in India in 2026?
Ans. Sequent Scientific (SEQUENT) is the primary listed option, trading at PE 45.83 with ROE 7.07%. Other significant players including Virbac Animal Health India and Zydus Animal Health operate as subsidiaries without separate listing access.
Why is India’s animal health listed universe so thin?
Ans. Many significant veterinary pharmaceutical companies operate as subsidiaries of larger domestic or international pharmaceutical groups (Zydus Animal Health, Virbac India) rather than as standalone listed entities, limiting direct public equity access.
What does Sequent Scientific manufacture?
Ans. Sequent Scientific manufactures veterinary active pharmaceutical ingredients and formulations for global markets, serving livestock and companion animal health applications internationally.
How does companion animal care benefit animal health stocks?
Ans. Rising pet ownership and willingness to spend on pet healthcare in urban India creates a growing new demand category for animal health and veterinary pharmaceutical stocks beyond traditional livestock-focused products.
Why does Sequent Scientific trade at a premium PE?
Ans. Sequent Scientific’s PE of 45.83, above the animal health and veterinary pharmaceutical stocks sector average, likely reflects its global manufacturing scale and growth potential in veterinary pharmaceutical exports, despite modest current ROE.
How do I invest in animal health and veterinary pharmaceutical stocks in India?
Ans. Open a demat account with a SEBI-registered broker. Sequent Scientific is currently the primary viable listed option. Monitor export order growth. Consult a SEBI-registered investment advisor before investing.
